We are live on
!
Find out more
Madrigal Pharmaceuticals
MDGL
MDGL
31 hedge funds and large institutions have $20.1M invested in Madrigal Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
57% more capital invested
Capital invested by funds: $12.8M → $20.1M (+$7.28M)
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
11.63% more ownership
Funds ownership: 0% → 11.63% (+12%)
0% more funds holding
Funds holding: 31 → 31 (0)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
31
Holders Change
–
Holders Change %
0%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
7
Increased
6
Reduced
5
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
CC
Caxton Corporation
Princeton,
New Jersey
|
-$6.42M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$332K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$208K |
| 4 |
Millennium Management
New York
|
-$205K |
| 5 |
Goldman Sachs
New York
|
-$153K |
